COPD By Alaina Darby.

Slides:



Advertisements
Similar presentations
GOLD MANAGEMENT PLAN FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Advertisements

Michael W. Nash, MD Family Medicine Clinton County Rural Health Clinic Understanding COPD.
Professor of Respiratory Medicine
COPD Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm)
Asthma and COPD Roger Deering + Phil Thirkell. Asthma - Definition A chronic inflammatory disorder of the airways… Symptoms usually associated with variable.
CHRONIC OBSTRUCTIVE PULMONARY DISEASE Treatment Opportunities in a Heartsink Disease Jim Reid.
Management of Patients With Chronic Pulmonary Disease.
COPD MANAGEMENT FALLS SHORT AT RCRMC Jean Solomon, M.D.
COPD Alison Boland StR Respiratory medicine. Aims & Objectives Overview of COPD Recap basic knowledge Update on COPD Know when to use nebulisers and home.
COPD Joshua Jewell. Epidemiology 8% of all individuals 10% age >40 6 th leading cause of death worldwide th in U.S. - >120,000 Expected 3 rd 2020.
Chronic obstructive pulmonary disease (COPD) Professor Bill MacNee
Central Ohio Pulmonary Disease, Inc. Michael L. Corriveau, MD, FACP, FCCP.
COPD Management of Stable COPD Shyam Rao May 2014.
Management of Chronic Airflow Obstruction J.R. Sheller, M.D. Allergy, Pulmonary & Critical Care Medicine.
Chronic Obstructive Pulmonary Disease. Why COPD is Important ? COPD is the only chronic disease that is showing progressive upward trend in both mortality.
GOLD Website Address
Habib GHEDIRA, MD, Prof. Medical Faculty of Tunis
COPD update Prof. Ramadan Nafae By
Matt Wong + Sheila Murphy Dec 13 th  AKT MINI EXAM  NICE – COPD GUIDELINES  BTS ASTHMA GUIDELINES  INHALER TECHNIQUE  QOF  SPIROMETRY  CSA.
© 2013 Global Initiative for Chronic Obstructive Lung Disease
Bronchial Asthma  Definition  Patho-physiology  Diagnosis  Management.
يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11 بسم الله الرحمن الرحیم با سلام.
COPD – PBL 8. Hypercapnia (  CO 2 )Hypoxia (  O 2 ) HyperventilationDyspnoea AsterixisHeadaches/fatigue Flushed skinCynosis Disturbed sleepTachapneoa.
Chronic obstructive pulmonary disease Edited by Chien-Da Huang Physician Educator/Associate Professor Department of Thoracic Medicine and Medical Education.
COPD (Chronic Obstructive Pulmonary Disease)
GOLD Update 2011 Rabab A. El Wahsh, MD. Lecturer of Chest Diseases and Tuberculosis Minoufiya University REVISED 2011.
Andriy Lepyavko, MD, PhD Department of Internal Medicine № 2.
Chronic Obstructive Pulmonary Disease Austin Paul K.
Exacerbations. Exacerbations An exacerbation of COPD is an acute event characterized by a worsening of the patient’s respiratory symptoms that is beyond.
© IPCRG 2007 COPD -Management of stable disease WONCA meeting Istanbul October 2015 Svein Høegh Henrichsen Oslo, Norway.
Percent Change in Age-Adjusted Death Rates, U.S., Proportion of 1965 Rate –59% –64% –35% +163% –7% Coronary.
Andriy Lepyavko, MD, PhD Department of Internal Medicine № 2.
Course in the Ward Oxygen saturation was 85-88% despite oxygen per mask at 5-6 lpm. She was nebulized with salbutamol and post-nebulization parameters.
History Taking Zinc code: UKACL1878ea Date of preparation May 2015 AstraZeneca provided funding & reviewed for technical accuracy.
LSU Journal Club Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD WISDOM study H. Magnussen MD, et al. Nisha Loganantharaj, PGY1 April 21,
Chronic Obstructive Pulmonary Disease 연세대학교 의과대학 응급의학교실 강사 조준호.
СOPD Chronic obstructive pulmonary disease (COPD), a common preventable and treatable disease, is characterized by persistent airflow limitation that.
ASTHMA Definition: Asthma is a chronic lung disease due to inflammation of the airways resulted into airway obstruction. The obstruction is reversible.
Management of stable chronic obstructive pulmonary disease (2) Seminar Training Primary Care Asthma + COPD D.Anan Esmail.
Clinical Applications of Spirometry for Pediatric Asthma
Azithromycin – for better or worse in chronic lung infection? Professor Emma Baker Professor of Clinical Pharmacology St George's, University of London.
Chronic Obstructive Pulmonary Disease Clinacal Pharmacy.
Obstructive lung disease
GOLD 2017 major revision: Summary of key changes
Current management of COPD and when to refer?
Respiratory Initiatives: GOLD - ABCD, CAT Scores and myCOPD
Pulmonary Center of Excellence
COPD 2003.
Chronic Obstructive Pulmonary Disease(COPD)
COPD – Primary Care Update
Asthma guidelines and treatment
Management of Chronic Airflow Obstruction
Management of Severe Asthma and COPD
Management of Stable COPD
Therapeutics 2 Tutoring: Asthma
COPD Tutoring – Part 1 By Alaina Darby.
COPD Tutoring – Part 2 By Alaina Darby.
Asthma By Alaina Darby.
COPD Dr MAMATHA SARTHI GPST3.
PHARMACOTHERAPY - I PHCY 310
Chronic obstructive pulmonary disease
PHARMACOTHERAPY - I PHCY 310
بیماریهای مزمن انسدادی ریه COPD
Long-Acting Agents in Severe COPD
COPD Exacerbation (1) C.L.I.P.S.
West Essex Frailty Pathway: COPD
PHARMACOTHERAPY - I PHCY 310
Chronic Obstructive Pulmonary Disease
William P. Saliski Jr. DO Montgomery Pulmonary Consultants
Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification based on symptom and risk evaluation. a) GOLD model of symptom/risk evaluation.
Presentation transcript:

COPD By Alaina Darby

How long does it take after quitting for risk of coronary heart disease to decrease by 50%? 12 hours 2 weeks 6 months 1 year 5 years d

How long does it take after quitting to see improvement in lung function? 12 hours 2 weeks 6 months 1 year 5 years b

Which of the following leads to emphysema? Loss of cilia Goblet cell hyperplasia Elastin destruction Mucus plugging c

JR has been a smoker for 30 years and was recently diagnosed with COPD JR has been a smoker for 30 years and was recently diagnosed with COPD. Which of the following causes his pursed lip breathing? Airway inflammation due to increased mucus and protease activity Hyperinflation due to inspiratory muscle dysfunction Pulmonary hypertension due to ventilation/perfusion mismatch Decreased gas exchange due to increased airway resistance d

Which of the following is least likely to be seen in JR? Macrophages Eosinophils Neutrophils CD8+ T cells b

BD has smoked for 45 years. How often would you like to perform spirometry on this patient to screen for COPD? Every year Every 2 years Every 5 years Not until he has symptoms

For assessing JR, which of the following measures would you most likely use? RV TLC FVC FRC c

Which of the following would be diagnostic of COPD? FEV1/FVC < 70% FEV1/FVC < 80% FVC/FEV1 < 70% FVC/FEV1 < 80% a

Spirometry on TD found his FEV1/FVC to be 76% Spirometry on TD found his FEV1/FVC to be 76%. His FEV1 was 72% of predicted. What Gold class should he be placed into? I II III IV N/A e

Spirometry on SD found his FEV1/FVC to be 55% Spirometry on SD found his FEV1/FVC to be 55%. His FEV1 was 72% of predicted. What Gold class should he be placed into? I II III IV N/A b

Which of the following is properly matched to patient category? A: Gold III B: CAT 8 C: 3 exacerbations D: mMRC 1 c

Which of the following is not true of bronchodilators in COPD? Increase FEV1 Mortality benefit PRN or scheduled dosing Improve exercise performance b

Spirometry on AD found her FEV1/FVC to be 45% Spirometry on AD found her FEV1/FVC to be 45%. Her FEV1 was 62% of predicted. Her CAT score is 12. What medication(s) would be most appropriate? Albuterol Salmeterol Albuterol + Ipratropium Fluticasone + Salmeterol b

Which of the following causes bronchodilation through inhibition of phosphodiesterase and is a CNS stimulant? Albuterol Tiotropium Theophylline Roflumilast c

VR is a 55 y/o woman with no hospital or ER insurance who has recently been diagnosed with COPD. She was placed in Gold I, has no known exacerbations, and a CAT score of 14. Which of the following is likely MOST appropriate? Albuterol Salmeterol Ipratropium Fluticasone + Salmeterol c

SR is taking theophylline for her COPD SR is taking theophylline for her COPD. She has recently started having headaches, diarrhea, nausea, and dizziness. Which of the following medications may have recently be started? Phenytoin Fluvoxamine Roflumilast Carbamazapine b

Which of the following patients would benefit from roflumilast? Class A patient adherent to her albuterol Class B patient nonadherent to her salmeterol Class C patient adherent to her fluticasone/salmeterol Class D patient nonadherent to her mometasone/fomoterol + ipratropium c

Which of the following COPD patients should get the PPV-23? 60 y/o with FEV1 of 45% 70 y/o with FEV1 of 75% 50 y/o with FEV1 of 55% 45 y/o with FEV1 of 65% b

Which of the following has been shown to decrease mortality in COPD patients? Antibiotics LABA Oxygen LAMA ICS c

Which of the following would not be included in the assessment if HG was thought to be having a COPD exacerbation? Pulse oximetry Medical history EKG CBC BMP Spirometry CXR f

Which of the following is the initial treatment for a COPD exacerbation? Bronchodilator Corticosteroid Oxygen Antibiotics c

Which of the following would be a suitable oxygen saturation for a COPD patient undergoing an exacerbation? 86% 90% 94% 98% b

Which of the following is the preferred bronchodilator for COPD exacerbation? Theophylline Salmeterol Albuterol + ipratropium Albuterol + tiotropium c

JR was given albuterol + ipratropium JR was given albuterol + ipratropium. Which of the following symptoms is most likely due to the ipratropium component? Palpitations Tachycardia Nervousness Tremor a

What is not a reason that a corticosteroid should be given? Shorter LOS Better lung function Mortality benefit Reduced treatment failure c

Which of the following is the most appropriate dosing for corticosteroids? 30 mg prednisolone PO Q day x 7 days 1 mg budesonide nebulized Q day x 7 days 30 mg prednisolone PO Q day x 5 days 1 mg budesonide nebulized Q day x 5 days c

Which of the following antibiotics would be the LEAST appropriate therapy? Aminopenicillin Macrolide Fluroquinolone Tetracycline c

Which of the following patients would not be indicated for antibiotics? Increased dyspnea and sputum volume Increased sputum volume and purulence Increased dyspnea and sputum purulence Mechanical ventilation a

Which of the following would be a suitable duration of therapy for antibiotics? 4 days 7 days 14 days 21 days b

Which of the following would be a suitable duration of therapy for antibiotics and steroids? Antibiotics for 7 days and steroids for 7 days Antibiotics for 14 days and steroids for 7 days Antibiotics for 7 days and steroids for 5 days Antibiotics for 14 days and steroids for 5 days c